Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or Hip
Fentanyl Matrix for the Treatment of Pain Caused by Osteoarthritis of the Knee or Hip: Improvement of Pain and Function: Multicenter, Open-label, Prospective, Observational Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who complain of chronic pain caused by osteoarthritis of the knee or hip persisting for 3 months or longer
- Patients who can fully observe the overall clinical study requirements including K-WOMAC completion at the investigator's discretion
- Patients who complain of severe pain (NRS score = 7) because pain was not treated enough with the previous analgesic
- Patients who have never been administered strong opioid analgesics over the last one month
Exclusion Criteria:
- Patients with a history of the drug or alcohol abuse in the past or now
- Childbearing women who are pregnant or likely to be pregnant during the study period and male subjects who are neither infertile nor willing to refrain from sexual relations but whose partner does not conduct an effective contraception (implant, injections, oral contraceptives, intrauterine device, etc.)
- Patients who are unable to use a transdermal system due to skin disease
- Patients with serious mental disorder
- Patients with history of hypersensitivity to opioid analgesics
- Patients with history of CO2 retention
- Patients who are not eligible for the study participation based on warnings, precautions and contra medications in the package insert of the study drug at the investigator's discretion
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
001
fentanyl matrix Knee osteoarthritis starting with 12mcg/h (flexible dose)
|
Knee osteoarthritis, starting with 12mcg/h (flexible dose)
Hip osteoarthritis, starting with 12mcg/h (flexible dose)
|
|
002
fentanyl matrix Hip osteoarthritis starting with 12mcg/h (flexible dose)
|
Knee osteoarthritis, starting with 12mcg/h (flexible dose)
Hip osteoarthritis, starting with 12mcg/h (flexible dose)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in pain intensity from baseline through final evaluation as measured by Numeric Rating Scale
Time Frame: Baseline and week 8
|
Baseline and week 8
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improvement of sleep disturbance
Time Frame: baseline, week 4 and week 8
|
baseline, week 4 and week 8
|
|
Improved pain relief as measured using the K-WOMAC scale
Time Frame: baseline, week 4 and week 8
|
baseline, week 4 and week 8
|
|
Impact of activity of daily activities measured by 5-point likert scale and social activities measured by 5-point likert scale
Time Frame: baseline, week 4 and week 8
|
baseline, week 4 and week 8
|
|
Investigator and patient global assessment measured by 5-point likert scale
Time Frame: Week 4 and week 8
|
Week 4 and week 8
|
|
Improved pain relief as measured using the CGI-I
Time Frame: Week 4 and week 8
|
Week 4 and week 8
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Fentanyl
Other Study ID Numbers
Other Study ID Numbers
- CR015454
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.